Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 193 pages)

 

Export 15 results:
Author Title [ Type(Desc)] Year
Filters: Author is Platt, R. W.  [Clear All Filters]
Journal Article
L. L. Lipscombe, Austin, P. C., Alessi-Severini, S., Blackburn, D. F., Blais, L., Bresee, L., Filion, K. B., Kawasumi, Y., Kurdyak, P., Platt, R. W., Tamim, H., and Paterson, J. M., “Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data”, Schizophr Res, vol. 154, pp. 54-60, 2014.
A. Mehrabadi, Reynier, P., Platt, R. W., and Filion, K. B., “Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1316-1324, 2018.
M. Eberg, Platt, R. W., and Filion, K. B., “The Estimation of Gestational Age at Birth in Database Studies”, Epidemiology, vol. 28, pp. 854-862, 2017.
M. Eberg, Platt, R. W., Reynier, P., and Filion, K. B., “Estimation of high-dimensional propensity scores with multiple exposure levels”, Pharmacoepidemiol Drug Saf, 2019.
M. H. Secrest, Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., Doyle, C. M., Dell'Aniello, S., and Filion, K. B., “Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research”, Pharmacoepidemiol Drug Saf, 2019.
B. M. Hicks, Yin, H., Yu, O. H., Pollak, M. N., Platt, R. W., and Azoulay, L., “Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink”, Bmj, vol. 355, p. i5340, 2016.
S. M. Grandi, Vallee-Pouliot, K., Reynier, P., Eberg, M., Platt, R. W., Arel, R., Basso, O., and Filion, K. B., “Hypertensive Disorders in Pregnancy and the Risk of Subsequent Cardiovascular Disease”, Paediatr Perinat Epidemiol, vol. 31, pp. 412-421, 2017.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., “Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 363, p. k4880, 2018.
K. B. Filion, Azoulay, L., Platt, R. W., Dahl, M., Dormuth, C. R., Clemens, K. K., Hu, N., Paterson, J. M., Targownik, L., Turin, T. C., Udell, J. A., and Ernst, P., “A Multicenter Observational Study of Incretin-based Drugs and Heart Failure”, N Engl J Med, vol. 374, pp. 1145-54, 2016.
M. H. Secrest, Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., and Filion, K. B., “Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example”, Pharmacoepidemiol Drug Saf, 2019.
Y. Lian, Yin, H., Pollak, M. N., Carrier, S., Platt, R. W., Suissa, S., and Azoulay, L., “Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer”, Eur Urol, vol. 70, pp. 808-815, 2016.
M. Tuccori, Filion, K. B., Yin, H., Yu, O. H., Platt, R. W., and Azoulay, L., “Pioglitazone use and risk of bladder cancer: population based cohort study”, Bmj, vol. 352, p. i1541, 2016.
R. W. Platt, Delaney, J. A., and Suissa, S., “The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding”, Eur J Epidemiol, vol. 27, pp. 77-83, 2012.
M. Pang, Schuster, T., Filion, K. B., Eberg, M., and Platt, R. W., “Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research”, Epidemiology, vol. 27, pp. 570-7, 2016.
S. M. Grandi, Reynier, P., Platt, R. W., Basso, O., and Filion, K. B., “The timing of onset of hypertensive disorders in pregnancy and the risk of incident hypertension and cardiovascular disease”, Int J Cardiol, vol. 270, pp. 273-275, 2018.
[Page last reviewed 6 December 2019]